Loading...
Loading...
Browse all stories on DeepNewz
VisitWhat will be Moderna's stock price change by January 31, 2025?
Remains 20% or more below pre-announcement level • 25%
Recovers to within 10% of pre-announcement level • 25%
Exceeds pre-announcement level • 25%
Other • 25%
Publicly available stock market data from exchanges like NASDAQ
Moderna Lowers 2025 Revenue Forecast to $1.5B–$2.5B; Shares Plunge 20% Pre-Market
Jan 13, 2025, 12:31 PM
Moderna Inc. lowered its 2025 revenue forecast to a range of $1.5 billion to $2.5 billion, down from previous estimates of $2.5 billion to $3.5 billion and below analysts' expectations of $2.95 billion, due to slower-than-expected demand for its COVID-19 and RSV vaccines. The company also reported 2024 product sales of $3.0 to $3.1 billion and an ending cash balance of approximately $9.5 billion. In response to the reduced revenue outlook, Moderna plans to reduce its 2025 cash cost expenses by $1 billion and intends to implement additional cost reductions of $500 million in 2026. CEO Stéphane Bancel highlighted the company's focus on driving growth, with a pipeline of 10 vaccines. Following the announcement, Moderna's stock plunged up to 20% in pre-market trading, reaching its lowest levels since April 2020.
View original story
Increase by more than 20% • 25%
Decrease • 25%
Increase by less than 10% • 25%
Increase by 10% to 20% • 25%
$5B to $6B • 25%
More than $7B • 25%
Less than $5B • 25%
$6B to $7B • 25%
Increase by 0% to 10% • 25%
Decrease by 0% to 10% • 25%
Decrease by more than 10% • 25%
Increase by more than 10% • 25%
Decrease by more than 10% • 25%
Increase by more than 10% • 25%
Increase by 0-10% • 25%
Decrease by 0-10% • 25%
Above $500 • 25%
$400-$500 • 25%
$300-$400 • 25%
Below $300 • 25%
Decrease • 25%
No change • 25%
Increase by less than 10% • 25%
Increase by 10% or more • 25%
Decrease by 0-20% • 25%
Increase by more than 20% • 25%
Decrease by more than 20% • 25%
Increase by 0-20% • 25%
Below $400 • 25%
Above $600 • 25%
$500 to $600 • 25%
$400 to $500 • 25%
$200 to $250 • 25%
Above $300 • 25%
Below $200 • 25%
$250 to $300 • 25%
Decrease by more than 10% • 25%
Decrease by 0% to 10% • 25%
Increase by more than 10% • 25%
Increase by 0% to 10% • 25%
Achieves $1 billion reduction • 25%
Other • 25%
Fails to achieve $1 billion reduction • 25%
Exceeds $1 billion reduction • 25%